Literature DB >> 35862725

Cytokines and Signaling Networks Regulating Disease Outcomes in Leishmaniasis.

Amrita Saha1, Souravi Roy2, Anindita Ukil2.   

Abstract

Cytokines play crucial roles in commencing and coordinating the organized recruitment and activation of immune cells during infection. These molecular regulators play an important part in deciding the fate of disease outcomes in leishmaniasis, a parasitic disease of tropical and subtropical countries. T helper 1 (Th1) cell-mediated inflammatory cytokines usually play a host-protective role, while T helper 2 (Th2) cell activation produces an anti-inflammatory milieu necessary for parasite survival. It is noteworthy that in such a multifaceted disease, the role played by any particular cytokine cannot be generalized as either beneficial or detrimental. For example, a "host-favorable" cytokine in one form of the disease has been found to be "pathogen friendly" in another form of leishmaniasis. On the other hand, the complex signaling network regulating the production of cytokines is further complicated by the nature of the host as well as the presence of other cytokines in the milieu. The present review focuses on the differential roles played by cytokines and the intricate signaling network responsible for the regulation of such cytokines during infection by different species of Leishmania. While many more studies are required in the future to better understand the role of these molecules in both animal models and patient samples, current studies indicate that these molecules are potential candidates to be targeted for therapy against this deadly disease.

Entities:  

Keywords:  cytokines; leishmaniasis; macrophages; signaling pathways

Mesh:

Substances:

Year:  2022        PMID: 35862725      PMCID: PMC9387244          DOI: 10.1128/iai.00248-22

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.609


  82 in total

1.  Immunization with Leishmania donovani protein disulfide isomerase DNA construct induces Th1 and Th17 dependent immune response and protection against experimental visceral leishmaniasis in Balb/c mice.

Authors:  Ajay Amit; Manas R Dikhit; Ashish Kumar Singh; Vikash Kumar; Shashi S Suman; Ashu Singh; Akhilesh Kumar; Ajit Kumar Thakur; Vidyanand Ravi Das; Pradeep Das; Sanjiva Bimal
Journal:  Mol Immunol       Date:  2017-01-05       Impact factor: 4.407

2.  mTOR signaling pathway regulates the IL-12/IL-10 axis in Leishmania donovani infection.

Authors:  Satyanarayana Swamy Cheekatla; Amita Aggarwal; Sita Naik
Journal:  Med Microbiol Immunol       Date:  2011-05-13       Impact factor: 3.402

3.  Role and effect of IL-2 in experimental visceral leishmaniasis.

Authors:  H W Murray; G D Miralles; M Y Stoeckle; D F McDermott
Journal:  J Immunol       Date:  1993-07-15       Impact factor: 5.422

4.  IL-2 is necessary for the progression of leishmaniasis in susceptible murine hosts.

Authors:  F P Heinzel; R M Rerko; F Hatam; R M Locksley
Journal:  J Immunol       Date:  1993-05-01       Impact factor: 5.422

5.  IL-10- and TGF-beta-mediated susceptibility in kala-azar and post-kala-azar dermal leishmaniasis: the significance of amphotericin B in the control of Leishmania donovani infection in India.

Authors:  Samiran Saha; Smriti Mondal; Rajesh Ravindran; Swati Bhowmick; Dolanchampa Modak; Sudeshna Mallick; Mehboobar Rahman; Sourjya Kar; Ramaprasad Goswami; Subhasis Kamal Guha; Netai Pramanik; Bibhuti Saha; Nahid Ali
Journal:  J Immunol       Date:  2007-10-15       Impact factor: 5.422

6.  Insufficient generation of Th17 cells in IL-23p19-deficient BALB/c mice protects against progressive cutaneous leishmaniasis.

Authors:  Kirsten Dietze-Schwonberg; Beate Lorenz; Susanna Lopez Kostka; Beatrix Schumak; André Gessner; Esther von Stebut
Journal:  Exp Dermatol       Date:  2017-12-06       Impact factor: 3.960

7.  The Severity of Visceral Leishmaniasis Correlates with Elevated Levels of Serum IL-6, IL-27 and sCD14.

Authors:  Priscila L Dos Santos; Fabrícia A de Oliveira; Micheli Luize B Santos; Luana Celina S Cunha; Michelle T B Lino; Michelle F S de Oliveira; Manuela O M Bomfim; Angela Maria Silva; Tatiana R de Moura; Amélia R de Jesus; Malcolm S Duthie; Steven G Reed; Roque P de Almeida
Journal:  PLoS Negl Trop Dis       Date:  2016-01-27

Review 8.  Cytokines: Key Determinants of Resistance or Disease Progression in Visceral Leishmaniasis: Opportunities for Novel Diagnostics and Immunotherapy.

Authors:  Alti Dayakar; Sambamurthy Chandrasekaran; Suresh V Kuchipudi; Suresh K Kalangi
Journal:  Front Immunol       Date:  2019-04-05       Impact factor: 7.561

9.  The IL-33/ST2 axis is associated with human visceral leishmaniasis and suppresses Th1 responses in the livers of BALB/c mice infected with Leishmania donovani.

Authors:  Octavie Rostan; Jean-Pierre Gangneux; Claire Piquet-Pellorce; Christelle Manuel; Andrew N J McKenzie; Claude Guiguen; Michel Samson; Florence Robert-Gangneux
Journal:  mBio       Date:  2013-09-17       Impact factor: 7.867

10.  IL-23 and IL-27 Levels in Macrophages Collected from Peripheral Blood of Patients with Healing Vs Non-Healing Form of Cutaneous Leishmaniasis.

Authors:  S Tolouei; K Ghaedi; A Khamesipour; M Akbari; M Baghaei; Sj Hasheminia; M Narimani; Sh Hejazi
Journal:  Iran J Parasitol       Date:  2012       Impact factor: 1.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.